| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12. | Shimadzu Introduces CF3-C8030 for Advanced Nanoparticles and Biomolecules Separation | ||
| 03.12. | Cencora Expands Global 3PL Services and Cold Chain Capabilities | ||
| 03.12. | BD Expands Cell Analyzer Portfolio with New Configurations | ||
| 03.12. | Vetter Managing Director to Retire | ||
| 03.12. | Polyrizon Achieves Scaled Manufacturing Milestone for PL-14 Intranasal Allergy Spray | ||
| 03.12. | Thermo Fisher Scientific Expands Bioprocessing Capabilities Across Asia | ||
| 02.12. | Evonik Appoints President for the Americas Region | ||
| 02.12. | AGC Biologics, ATUM Partner to Shorten Timelines for Cell Line Development | ||
| 02.12. | WuXi Biologics Signs MoU with Qatar Free Zones Authority | ||
| 02.12. | Fresenius Kabi Expands Simplist Portfolio of Prefilled Syringes | ||
| 02.12. | Valo Health Names Rita Kale CFO | ||
| 02.12. | Rentschler Biopharma, Coriolis Pharma Partner for Integrated Biopharma Solutions | ||
| 01.12. | Cellares Appoints Ali Soleymannezhad as Chief Commercial Officer | ||
| 01.12. | Circle Pharma Taps Dr. Anne Borgman as CMO | ||
| 01.12. | Südpack Breaks Ground on New Pharma Packaging Facility in Erolzheim | ||
| 01.12. | Regeneron, Tessera Therapeutics Partner to Develop & Commercialize TSRA-196 | ||
| 01.12. | Vistagen Names Nick Tressler as Chief Financial Officer | ||
| 26.11. | FDA Clears AstraZeneca's IMFINZI Combo for Early Gastric and GEJ Cancers | ||
| 26.11. | eXmoor Pharma, Royal Free London Join Forces to Strengthen UK CGT Manufacturing Pathway | ||
| 25.11. | Sanofi and Regeneron's Dupixent Approved in EU | ||
| 25.11. | EU Clears Bristol Myers Squibb's Breyanzi for Mantle Cell Lymphoma | ||
| 25.11. | BioMed X, AbbVie Launch New Research Project Focused on Anhedonia | ||
| 24.11. | Roche Adopts Veeva Vault CRM | ||
| 24.11. | AstraZeneca to Invest $2B in Maryland | ||
| 21.11. | AGC Biologics Enters Gene Therapy Manufacturing Agreement with AAVantgarde |